See Full Document Text
GOVERNMENT OF INDIA
MINISTRY OF CHEMICALS AND FERTILIZERS
DEPARTMENT OF PHARMACEUTICALS
LOK SABHA
UNSTARRED QUESTION No. 2242
TO BE ANSWERED ON THE 31st JULY 2026
Jan Aushadhi Kendras in Uttar Pradesh
†2242. Shri Anoop Pradhan Valmiki:
Will the Minister of CHEMICALS AND FERTILIZERS be pleased to state:
(a) the number of Jan Aushadhi Kendra (JAKs) sanctioned/functional operational in Hathras
district of Uttar Pradesh till date;
(b) whether the Government is aware that a few JAKs have been closed due to problems like
below optimal sales, lesser prescription of generic medicines by the doctors and non-supply
of medicines in a timely manner in the said district, if so, the details thereof;
(c) whether the Government has conducted any investigation/review in this regard, if so, the
details thereof; and
(d) the steps being taken by the Government for operating JAKs in an effective manner
creating awareness regarding generic medicines and ensuring regular supply of medicines?
ANSWER
THE MINISTER OF STATE IN THE MINISTRY OF CHEMICALS AND
FERTILIZERS
(SMT. ANUPRIYA PATEL)
(a): Under Pradhan Mantri Bhartiya Janaushadhi Pariyojana, a total of 4,226 Jan Aushadhi
Kendras (JAKs) have been opened in the State of Uttar Pradesh as on 30.06.2026, of which
17 JAKs have been opened in the Hathras district.
(b): Yes Sir. In the Hathras district of Uttar Pradesh, 02 Jan Aushadhi Kendras have become
non-operational till 30.06.2026.
(c): The Pharmaceuticals and Medical Devices Bureau of India (PMBI), the implementing
agency of the scheme continuously monitors the functioning of Jan Aushadhi Kendras
through an IT-enabled monitoring system, regular review of sales and stock positions.
Further, the State Level Marketing Officer of PMBI, establishes contact with JAKs
whose sales are low with a view to help revive sales. PMBI handholds JAKs and organises
workshops, peer learning from successful JAK owners and meeting with doctors from the
local area for JAKs performing less well.(d): The Government has taken several measures to ensure the effective functioning of Jan
Aushadhi Kendras creating awareness regarding generic medicines and ensuring regular
supply of medicines. Details are as under:-
In order to promote acceptability and to increase sale of medicines supplied through
JAKs, targeted awareness campaigns about the benefits of Janaushadhi medicines are
conducted on a regular basis:
i. Awareness campaigns: Pharmaceuticals and Medical Devices Bureau of India
(PMBI), conducts awareness campaigns in coordination with bodies and platforms
such as the Central Bureau of Communication, PIB, MyGov and MY Bharat, in
various modes such as print, television, radio, social media platforms, outdoor
hoardings, community engagement, etc.
ii. Interactive messages/calls: Outreach and citizen engagement are also pursued through
WhatsApp chatbot and outbound calls to inform citizens regarding the quality of
Janaushadhi products and the large savings that accrue from purchase of the same from
nearest JAK.
iii. Jan Aushadhi Week: Jan Aushadhi Week is celebrated every year in the first week of
March during which special campaigns such as public rallies, health camps, seminars
in pharmacy colleges, children engagement programmes, etc. are conducted across the
nation to educate citizens, healthcare professionals and other stakeholders about the
benefits of Janaushadhi generic medicines.
iv. Messages from eminent persons: Audio/video messages from well-known persons
such as public representatives and eminent doctors are disseminated on social media
platforms to highlight the benefits of Janaushadhi medicines and dispel myths
associated with respect to their quality.
v. Public engagement programme in rural areas: To educate citizens in local
languages/dialects, publicity is also done through health camps, nukkad-natak,
audiovisual display at Common Service Centres and public engagement workshops in
association with local JAKs in rural areas.
In order to address any supply gaps and ensure smooth supply and availability of
products at JAKs, the following measures are in place:
(i) Since September 2024, stocking by JAKs of 200 commonly used medicines,
consisting of the 100 top-selling medicines in the scheme product basket and 100 fast-
selling medicines in the market, has been incentivised, under which JAK owners are
eligible for monthly incentive based on the stocks that they maintain for these
medicines.
(ii) An end-to-end information-technology-enabled supply chain system is in place to
connect a robust supply chain system consisting of five warehouses and a growing
network of distributors across the country, currently numbering 42.
(iii)In addition, with a view to ensure availability of commonly used products, 400 fast-
moving products are monitored regularly by Pharmaceuticals and Medical Devices
Bureau of India (PMBI), the scheme implementing agency, and demand for the same
is estimated on a continuous basis. Further, steps have been taken to digitise the
estimation method to augment the procurement process.
*****